Market Overview:
The global mice model market size is expected to reach USD 2.68 billion by 2032,exhibiting the CAGR of 7.8% during the forecast period.
The Mice Model Market is witnessing a robust increase in demand, driven by its critical role in biomedical research, particularly in the study of human diseases, drug development, and genetic research. The growth of this market is supported by advancements in gene editing technologies, such as CRISPR, which have expanded the capabilities of mice models to mimic human conditions more accurately. Additionally, the rising prevalence of chronic diseases and the increasing focus on personalized medicine are further propelling the demand for mice models. However, ethical concerns and regulatory scrutiny related to animal testing, as well as the high cost of maintaining and developing specialized mice strains, could influence market dynamics.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/mice-model-market/request-for-sample
Top Companies:
Understanding key players and their initiatives provides valuable insights into the competitive landscape and emerging opportunities in the market. Here are the top companies in the market:
- Charles River Laboratories International, Inc.
- Cyagen Biosciences Inc.
- Envigo
- genOway S.A.
- Harbour Biomed
- Hera Biolabs
- Inotiv
- Janvier Labs
- Ozgene Pty Ltd.
- PolyGene
- Sage Labs
- Taconic Biosciences, Inc.
- The Jackson Laboratory
- Trans Genic Inc.
Mice Model Market, Model and Service Outlook (Revenue – USD Billion, 2019-2032)
- Municipal Solid Waste
- Process Waste
- Agriculture Waste
- Others
Mice Model Market, Application Outlook (Revenue – USD Billion, 2019-2032)
- Neurology
- Oncology
- Cardiovascular Diseases
- Genetic Diseases
- Others
Mice Model Market, End User Outlook (Revenue – USD Billion, 2019-2032)
- Contract Research and Manufacturing Organizations
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
The research report categorizes the market into various segments and sub-segments. The primary segments covered in the study include type, application, end use and region. The splitting of the market into various groups enables businesses to understand market preferences and trends better. Also, stakeholders can develop products/services that align with the diverse needs of consumers in the industry. Besides, the research study includes a thorough examination of all the major sub-segments in the market.
Recent Developments:
- Biocytogen Launches RenNano Platform (December 2022)
Biocytogen introduced the RenNano platform, a fully human heavy-chain antibody solution. This addition to their existing RenMice family, alongside RenMabT and RenLite, accelerates the development of fully human monoclonal antibodies, as well as bispecific/multispecific antibodies and single-domain antibodies. The platform streamlines the antibody discovery process, facilitating the advancement of novel therapeutics. - Olink Holding AB Releases Olink Target 48 Mouse Cytokine Panel (September 2023)
Olink Holding AB launched the Olink Target 48 Mouse Cytokine Panel, a multiplexed protein panel that offers detailed insights into the murine immune system. The panel supports in-depth disease modeling, longitudinal studies, and translational research, providing a comprehensive tool for immunology and therapeutic research. - Taconic Biosciences Expands Immuno-Oncology Portfolio (January 2020)
Taconic Biosciences introduced the B2m-NOG mouse model, expanding its immuno-oncology portfolio. This model supports immune system studies and cancer research, providing a valuable tool for the development of immunotherapies and drug discovery in oncology.
The mice model market is influenced by drug discovery and development efforts. Mice models, particularly genetically engineered strains, play vital roles in pharmaceutical research. They closely replicate human physiology and genetics, aiding in studying disease mechanisms, evaluating drug effectiveness, and assessing safety profiles. Through preclinical trials, these models help uncover pharmacokinetics, pharmacodynamics, and potential adverse effects of new drug candidates. Furthermore, mice models assist in identifying therapeutic targets and biomarkers, accelerating drug development processes. With substantial investments in research and development by pharmaceutical firms to address unmet medical needs, the demand for mice models is poised to grow, driving advancements in drug discovery and development.